Veracyte | VCYT - Assets

Stock Price
38.48
Daily Change
-0.42 -1.08%
Monthly
16.50%
Yearly
31.78%
Q2 Forecast
37.71

Veracyte reported $1.44B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agenus USD 186.46M 40.34M Mar/2026
Agilent USD 12.81B 86M Dec/2025
Anika Therapeutics USD 179.39M 10.88M Mar/2026
Arrowhead Research USD 2.27B 664.08M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Heron Therapeutics USD 246.22M 9.66M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Intrexon USD 73.16M 77.88M Jun/2024
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
Laboratory Of America USD 19.09B 694.4M Mar/2026
Ligand Pharmaceuticals USD 1.53B 28.53M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
Rigel Pharmaceuticals USD 242.53M 35.8M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Siemens EUR 167.97B 2.16B Mar/2026
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Veracyte USD 1.44B 30.38M Mar/2026
Waters USD 24.53B 19.45B Mar/2026